Stay updated on Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision 3.5.4 in place of Revision 3.5.3, indicating a small update to the page or site template rather than changes to study details.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.3 appears in the page footer, replacing the previous Revision: v3.5.2. This reflects a minor maintenance update that does not alter study information.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no visible changes to the study details content.SummaryDifference0.0%

- Check42 days agoChange DetectedMantova, Italy has been replaced with Mantua, Italy in the locations list. The city name is updated to its common English form to improve clarity for participants and searchability.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded Severe myoclonic epilepsy in infancy as a related topic and introduced a Genetic and Rare Diseases Information Center resource in the Resources section.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoved the study's condition label 'Dravet syndrome' and the Genetic and Rare Diseases Information Center resource from the page.SummaryDifference0.1%

Stay in the know with updates to Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.